Prostate Cancer Supportive Care (PCSC) Program: A model for meeting an unmet need for patients with PC.

Authors

Celestia Higano

Celestia S. Higano

University of British Columbia, Vancouver, BC, Canada

Celestia S. Higano , Monita Sundar , Christine Zarowski , Meghan Lui , Nicholas Pratap , Joy Egilson , Andrea Holmes , Nikita Ivanov , Marcy Dayan , Anna Hudon-Kaide , Paul Griggs , Corinne Maurice-Dror , Rosalie Ho , Daniella Sare , Angela Hwang , Ryan Flannigan

Organizations

University of British Columbia, Vancouver, BC, Canada, Prostate Cancer Supportive Care Program, Vancouver, BC, Canada, BC Cancer Vancouver Centre, Vancouver, BC, Canada

Research Funding

No funding sources reported

Background: Prostate cancer (PC) patients (pts) face treatment-related sequelae that affect their quality of life. The PCSC Program was created in 2013 and is located in the Vancouver Prostate Centre’s urology clinic. It is a clinical, educational, and evidence-based program that addresses challenges experienced by PC pts from the time of diagnosis onward. The program consists of 8 “modules,” each designed to support a specific concern. Methods: We describe the operational details of the PCSC Program and its metrics. Results: The program consists of a Medical Director and Program Manager who articulate the mission, oversee the day-to-day operations, and hire and manage the allied health clinicians and administrative staff. Clinicians include two sexual health RNs (1.4 FTE), two pelvic floor physiotherapists, a nurse practitioner, a registered dietitian, two clinical exercise physiologists, and two clinical counselors (all 0.2 FTE). A sexual health urologist is in the clinic, and a medical oncologist delivers the metastatic disease module. As of 09/2023, 3562 pts registered for this no-cost program (Table). Pts choose modules relevant to their interests and needs. The program supports free language interpretation services to non-English speaking pts. Translation of education session recordings is currently underway. In 4/2020, in response to the COVID-19 pandemic, the real-time group education sessions and clinic appointments transitioned from in-person to hybrid delivery, with virtual options enabling the participation of pts from throughout British Columbia. PCSC maintains high patient satisfaction, as indicated by responses to patient satisfaction questionnaires. Conclusions: The need for PC supportive care is well recognized but may be challenging when the services are fragmented, costly, and time-consuming to orchestrate. All modules offered by the PCSC Program can be accessed with one registration and are conveniently housed in one location, which also facilitates clinician communications across disciplines. We attribute the success of our program and high patient satisfaction to this model and our team approach to the individual patient’s needs.

ModulesAttendees, nGroup Education,
(# sessions)
Clinic Appointments,
(# appointments)
Mean Overall Satisfaction*
(# respondents)
Introduction to PC and Primary Treatment Options10041004 (162)not applicable4.8 (91)
Managing Sexual Function and Intimacy1880869 (127)1587 (6515)4.6 (71)
Management of side effects of ADT465391 (98)214 (318)4.2 (22)
Pelvic Floor Physiotherapy for Incontinence1394953 (98)949 (2540)4.7 (138)
Counselling47935 (2)472 (1732)5.0 (11)
Metastatic Disease Management9393 (33)not applicable4.6 (13)
Nutrition825569 (66)398 (641)4.6 (122)
Exercise875477 (73)710 (2288)4.6 (38)

*One-year data 08/22 to 08/23: Satisfaction Survey scale 1-5, with 1 lowest, 5 highest.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 308)

DOI

10.1200/JCO.2024.42.4_suppl.308

Abstract #

308

Poster Bd #

M21

Abstract Disclosures

Similar Abstracts

First Author: Daniel Abido Galvao

First Author: Thorgerdur Palsdottir

Abstract

2024 ASCO Genitourinary Cancers Symposium

Endocrine and metabolic diseases among survivors of prostate cancer in a population-based cohort.

First Author: Siqi Hu